Luca Mezzetto, Mario D'Oria, Enrico Gallitto, Nicola Troisi, Ciro Ferrer, Elisa Zanetti, Beatrice Grando, Davide Mastrorilli, Rocco Giudice, Raffaella Berchiolli, Mauro Gargiulo, Sandro Lepidi, Gian F Veraldi
BACKGROUND: Endovascular treatment is nowadays accepted as first-line treatment for most patients with aorto-iliac obstructive disease (AIOD), including those with Trans-Atlantic Inter-Society Consensus II (TASC-II) lesion types C and D. Aim of the study was to evaluate the role of Viabahn VBX (W. L. Gore and Associates, Flagstaff, AZ, USA), in patients with chronic occlusive aorto-iliac disease (ChO). METHODS: A retrospective review of patients undergone elective endovascular repair with VBX (W...
April 15, 2024: Journal of Cardiovascular Surgery